Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan
- PMID: 2664172
Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan
Abstract
Twenty-four different antigens from 6 strains of streptococcus were prepared for skin testing and delayed hypersensitivity testing. The induction of Behçet's disease symptoms by these antigens was studied. Delayed skin reactions to whole cells and cell walls of streptococci were frequently observed in Behçet's disease, but only a few skin reactions were observed in other diseases and healthy controls. The skin reactions to the other bacteria were also strong in Behçet's disease, but the differences between Behçet's disease and the other diseases were not significant. Interestingly, the induction of systemic Behçet's disease symptoms was observed after the streptococcus skin test in 15 of 85 cases tested, but no case of induction by the other bacteria was observed. Our study supports the possible pathogenetic role of certain streptococcal antigens in Behçet's disease.
Similar articles
-
Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test.J Rheumatol. 1988 Jun;15(6):1029-30. J Rheumatol. 1988. PMID: 3418627
-
Behçet's disease.Curr Opin Rheumatol. 1991 Feb;3(1):32-5. Curr Opin Rheumatol. 1991. PMID: 2043450 Review.
-
Behçet's disease and streptococcal infection.Jpn J Ophthalmol. 1986;30(4):385-401. Jpn J Ophthalmol. 1986. PMID: 3586405
-
Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.J Eur Acad Dermatol Venereol. 2005 Sep;19(5):569-72. doi: 10.1111/j.1468-3083.2005.01250.x. J Eur Acad Dermatol Venereol. 2005. PMID: 16164710
-
[Behçet's disease and streptococcal antigens].Nippon Ganka Gakkai Zasshi. 1996 Mar;100(3):173-80. Nippon Ganka Gakkai Zasshi. 1996. PMID: 8900580 Review. Japanese.
Cited by
-
Behçet's syndrome pathophysiology and potential therapeutic targets.Intern Emerg Med. 2014 Apr;9(3):257-65. doi: 10.1007/s11739-013-1036-5. Epub 2014 Jan 12. Intern Emerg Med. 2014. PMID: 24415351 Review.
-
Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.Clin Exp Immunol. 2004 Jul;137(1):201-8. doi: 10.1111/j.1365-2249.2004.02520.x. Clin Exp Immunol. 2004. PMID: 15196263 Free PMC article. Clinical Trial.
-
Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats.Clin Exp Immunol. 1994 Aug;97(2):226-31. doi: 10.1111/j.1365-2249.1994.tb06072.x. Clin Exp Immunol. 1994. PMID: 7519530 Free PMC article.
-
Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.Rheumatol Int. 2007 Mar;27(5):417-24. doi: 10.1007/s00296-006-0281-6. Rheumatol Int. 2007. PMID: 17171346 Review.
-
Behçet's Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet's Disease Patients.Front Immunol. 2020 Jun 12;11:1192. doi: 10.3389/fimmu.2020.01192. eCollection 2020. Front Immunol. 2020. PMID: 32595645 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical